Skip to content

A COMPREHENSIVE REPORT FOR DECISION MAKING

Oncology DRUG Intelligence

2024

Two Reports providing complete landscape on oncology drug development

RELEASED - August 2024

2500

Oncology Drug Discovery Companies Worldwide

Oncology Drug Intelligence 2024 is a set of two comprehensive intelligence reports offering complete insights to identify and connect with the largest number of active oncology drug discovery companies.

oncology Drug intelligence 2024
14th Updated Edition

Two Reports Covers all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

Provides Complete Landscape on Latest Oncology Drug Development covering Emerging Technologies, Partnering and Funding Status in the Domain.

Drug Developers with proper funding, technologies and pipeline are only included. No Acquired, Merged or Dormant Stage Cancer Targeting Drug Developer is included.

Oncology drug intelligence 2024
largest coverage

providing intelligence at fingertips

Countries
1

Worldwide 38 Countries Covered. Largest Coverage Guaranteed

Drug Developers
500

Includes 1250 Clinical Stage & 1250 Early Stage Oncology Drug Discovery Companies

Unique Molecules in Development
500

Includes – Individual Drug Mechanism of Action & Drug Targets.

Cancer Targets
1 +

Covers complete Emerging Cancer Drug Targets Details with Numerous Technologies

TWO REPORTS

Intelligence @ fingertips

identify new opportunities

TWO Oncology reports

360 Degree Insights on Drug Development

  • 2500 Active Cancer Drug Developers.
  • 4800+ Active Molecules in Development.
  • 1700+ Deals & Partnering Details.
  • Special coverage on CAR-T, Vaccines, ADCs, Monoclonal Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
  • Emerging Technologies like Microbiome, CRISPER, Exosomes, RNAi etc., as Cancer treatment are covered.

Perfect Solution

Unique first in class Intelligence Report

Trusted by

BUSINESS LEADERS -WORLDWIDE